1-20 of 20
Michael DeBaun, MD, MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

2018: The Year's Best in Sickle Cell Disease

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 16 (1)
https://doi.org/10.1182/hem.V16.1.9283
Published: 2018
Articles

A New Therapy for Sickle Cell Disease: FDA Approves Oral L-glutamine for Prevention of Acute Vaso-occlusive Events in Children and Adults

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (6)
https://doi.org/10.1182/hem.V15.6.9016
Published: 2018
Articles

A New Strategy for the Prevention of Adverse Maternal and Fetal Outcomes in Pregnant Women With Sickle Cell Disease: The Oxygen Therapy and Pregnancy in SCD Trial (DR02G)

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (5)
https://doi.org/10.1182/hem.V15.5.8889
Published: 2018
Articles

Another Sickle Cell Trait Myth Bites the Dust: Sickle Cell Trait Is Not Associated With Ischemic Stroke

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (4)
https://doi.org/10.1182/hem.V15.4.8757
Published: 2018
Articles

Professionalism and the Written Word: Attitudes and Words Matter in Medical Care for Adults With SCD

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (3)
https://doi.org/10.1182/hem.V15.3.8461
Published: 2018
Articles

What We Know and Do Not Know About Chronic Pain in Adults With Sickle Cell Disease

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (2)
https://doi.org/10.1182/hem.V15.2.8264
Published: 2018
Articles

The Year's Best in Sickle Cell Disease for 2017

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (1)
https://doi.org/10.1182/hem.V15.1.8159
Published: 2018
Articles

Yet Another Complication of Sickle Cell Disease: High Incidence of Venous Thromboembolism and Its Association With Earlier Death

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (6)
https://doi.org/10.1182/hem.V14.6.7789
Published: 2017
Articles

Another Myth About Sickle Cell Trait Bites the Dust

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (5)
https://doi.org/10.1182/hem.V14.5.7573
Published: 2017
Articles

Cautiously Optimistic About Gene Therapy in Sickle Cell Disease: A New Arrow in the Quiver for Cure

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7463
Published: 2017
Articles

Another Therapeutic Agent in the Pipeline for Preventing Acute Vaso-Occlusive Events in Sickle Cell Disease

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (3)
https://doi.org/10.1182/hem.V14.3.7267
Published: 2017
Articles

A New Phase II Agent Holds Promise for First FDA Approved Therapy for Treatment of Acute Vaso-Occlusive Pain Events in SCD

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7115
Published: 2017
Articles

The Year's Best in Sickle Cell Disease

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.6994
Published: 2017
Articles

Universal Precautions Help Decrease Rate of Exercise-Related Death in Patient With Sickle Cell Trait

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (6)
https://doi.org/10.1182/hem.V13.6.6722
Published: 2016
Articles

Confirming a Reasonable Next Step for HSCT in Children with Hemoglobinopathies

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (5)
https://doi.org/10.1182/hem.V13.5.5966
Published: 2016
Articles

When Is a Negative Phase III Trial Positive in Sickle Cell Anemia?

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (4)
https://doi.org/10.1182/hem.V13.4.5626
Published: 2016
Articles

Comparing Outcomes for Young Adults with Severe SCD Treated with HLA-Identical Sibling and Matched Unrelated HCT versus Standard Supportive Care

Sarah-Jo Stimpson, MD, Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (3)
https://doi.org/10.1182/hem.V13.3.5469
Published: 2016
Articles

The TWiTCH Trial

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (2)
https://doi.org/10.1182/hem.V13.2.4943
Published: 2016
Articles

ASH Program Successful in Promoting Minority Careers

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2011) 8 (2)
https://doi.org/10.1182/hem.V8.2.1280
Published: 2011
Articles

ASH Co-Sponsors Inaugural National Conference on Blood Disorders in Public Health and Promotes the Important Role of Hematologists

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2010) 7 (4)
https://doi.org/10.1182/hem.V7.4.6402
Published: 2010